Qld scientist recognised for cancer study
Robyn Wuth |
A Queensland scientist at the forefront of international genetic cancer research has been recognised for her groundbreaking study of breast, ovarian and other cancers.
Professor Georgia Chenevix-Trench, from the QIMR Berghofer Medical Research Institute, has been awarded the 2022 GSK Award for Research Excellence for developing personalised risk prediction methods and accelerating cancer research worldwide.
Breast cancer is the most common cancer affecting Australian women, with approximately 57 people diagnosed every day in 2022.
Professor Chenevix-Trench’s research has helped the scientific community better understand those at risk of the disease.
“I’ve had an interest in helping those affected by hereditary cancers my entire life,” the geneticist said.
“My focus has been to understand how genetic variants act as a determining factor in developing breast cancer. Unless we know how these genomes operate in relation to cancerous cells, we won’t be able to translate the knowledge we have gained into tangible treatment options and preventative solutions for patients.”
Professor Chenevix-Trench will use the $100,000 grant to purchase equipment for real-time cell analysis.
AAP
